STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		131 Months Ended
	Jan. 31, 2013	Jan. 31, 2012	Jan. 31, 2013
Revenue	$ 0	$ 0	$ 1,863,343
Operating Expenses
Research and Development Expenses	979,103	2,212,909	30,781,937
General and Administrative Expenses	1,201,951	1,031,392	28,070,461
Total Operating expenses	2,181,054	3,244,301	58,852,398
Loss from Operations	(2,181,054)	(3,244,301)	(56,989,055)
Other Income (expense):
Interest expense	(361,176)	(1,616,882)	(15,347,041)
Other Income (expense)	(19,898)	6,744	239,811
(Loss) Gain on note retirement	152,491	(697,642)	(840,451)
Net changes in fair value of common stock warrant liability and embedded derivative liability	(4,023,599)	839,750	17,018,697
Net Loss before benefit for income taxes	(6,433,236)	(4,712,331)	(55,918,039)
Income tax benefit	725,190	346,787	2,652,450
Net Loss	(5,708,046)	(4,365,544)	(53,265,589)
Dividends attributable to preferred shares	185,000	185,000	2,507,570
Net Loss applicable to Common Stock	$ (5,893,046)	$ (4,550,544)	$ (55,773,159)
Net Loss per share, basic and diluted (in dollars per share)	$ (0.01)	$ (0.02)
Weighted average number of shares outstanding, basic and diluted (in shares)	445,628,988	262,831,912